Clinical trial
Safety and Efficacy of an Ab Interno Gelatin Stent (XEN63) With or Without Mitomycin C
NCT04750447 is registered in ClinicalTrials.gov with Prism Eye Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of an Ab Interno Gelatin Stent (XEN63) With or Without Mitomycin C
- Lead sponsor
- Prism Eye Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 9, 2020
- Completion date
- June 9, 2023
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.